Diagnostic testing has become a fundamental aspect of healthcare, aiding physicians in diagnosing conditions and determining treatments. Despite a decline in COVID-19 testing affecting total revenues, core diagnostic segments have generally experienced growth. Factors such as new products, changes in global health spending, regulatory shifts, and disease trends contribute to a constantly changing market, yet one that remains resilient.

Key growing segments attracting industry attention include next-generation sequencing (NGS), personalized medicine, and mass spectrometry. Immunochemistry, point-of-care (POC) testing, and molecular diagnostics are also of significant interest, expected to play a crucial role in the future of IVD. The IVD market remains dynamic, characterized by constant innovations.

In Vitro Diagnostic (IVD) Trends and Market Update: March 2024 by Kalorama Information provides the most current insights into these trends and others shaping the market. This report reflects the latest information available.

In In Vitro Diagnostic (IVD) Trends and Market Update: March 2024, you’ll discover:

• What’s Driving Growth in the IVD Market in 2024
• What Major Trends are Affecting the Market in 2024
• What Product Trends and New Developments Will Shape the IVD Market in 2024

Trends highlighted throughout 2023 and into 2024 include:

• Growing interest in multiplex disease testing
• Increasing interest in digital diagnostics, combining data and analytics with traditional IVD
• Continued advancement of AI technologies
• Growth in rapid and POC testing
• And much more!

Kalorama Information remains dedicated to examining the IVD market and its evolving landscape, providing precise and up-to-date data through the expertise of its authors and its commitment to excellence in market analysis.